Texas Diabetes & Endocrinology, PA
Round Rock, Texas 78681
1 studies enrolling now · 15 studies all time
What they study most
Cardiovascular Diseases, Chronic Kidney Disease, Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Nonalcoholic Steatohepatitis, Obesity, Overweight, Overweight and Obesity, Overweight or Obesity, Type 1 Diabetes, Type 1 Diabetes Mellitus
Studies at this site
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide — Recruiting now
- Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes — Running, not enrolling
- A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
- A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
- A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight — Running, not enrolling
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight — Completed
- A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy — Completed
- A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin — Completed
- A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed
- A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program — Completed
- A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin — Completed
- A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities — Completed
- A Study of LY3209590 in Participants With Type 1 Diabetes — Completed
- A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes — Completed
- Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec — Completed